NEW YORK, Jan 5 – Proteomics company Structural Bioinformatics said Friday it has appointed Ian McDonald as vice president of drug discovery. McDonald was previously senior director of chemistry at Merck Research Laboratories.
NEW YORK, Jan 5 - Packard BioScience has decided to terminate its collaboration with Aclara BioSciences in which it was to be the exclusive distributor of Aclara’s Arteas LabCards, a microfluidics array technology, the companies said Friday.
NEW YORK, Jan 4 - Phylos, a privately held proteomics company that wants to develop the first high-throughput protein chip, announced Thursday that it had raised $25.1 million in a round of private financing. The Lexington, Mass.-based company's principal investors include Three
NEW YORK, Jan 4 - Informax said Thursday increased sales of Genomax and Vector NTI software would help to drive up fourth quarter revenues to $5.3 million while new bookings of $6.7 million in the quarter would generate strong revenues in the future. In a conference call to dis
NEW YORK, Jan 4 – Third Wave Technologies said Thursday it had licensed its Invader genotyping system to Fairview University Medical Center in Minneapolis for a genotyping study to be sponsored by the NIH. Terms of the deal were not disclosed, although
NEW YORK, Jan 3 - Israel’s Weizmann Institute of Science has signed DoubleTwist as the first commercial licensee for its GeneCards Encyclopedia, a web-based interface that offers biomedical information about the structure and function of human g
NEW YORK, Jan 3 - Java could be a killer app for visually modeling genomic data, but several important problems have to be addressed first, according to Shankar Subramaniam of University of California, San Diego.
NEW YORK, Jan 3 – Orchid BioSciences has granted PerkinElmer’s Life Sciences unit an exclusive license to its SNP-it single base primer extension technology for SNP scoring, the companies announced Wednesday.
NEW YORK, Jan 2 – Bayer and Zymark of Hopkinton, Mass. have developed a cell-based assay kit that allows laboratories to design assays for any gene target or type of cell and run an automated assay, the companies announced Tuesday.
NEW YORK, Dec 29 – Paradigm genetics has licensed the Rosetta Resolver gene expression analysis system from Rosetta Inpharmatics and Agilent Technologies, the companies announced Friday. The companies did not disclose the financial terms of the agreement.
NEW YORK, Dec 29 – Framingham Genomics Medicine, which planned to assemble, analyze, and sell data from the 52 year-old Framingham Heart Study, will disband after Boston University and the National Heart Lung and Blood Institute denied it access to
NEW YORK, Dec 28 – Science may have declared the sequencing of the human genome the top scientific advance of 2000, but Biography is honoring the achievements of the personalities behind the accomplishment.